The finances is one of the reasons I have steered clear of...

First 47 Last

Share
Profile

Follow
Novice2012

536 Posts.

32

22/02/19

07:42

Post #: 37525189
Share

Originally posted by CrazyGuy ↑

Here's a controversial prediction: headed for sub-$1.00 very quickly. And I'm guessing sub-$0.50 within a year.

Anthony Du Preez resigned as a director on 13 Feb, and is likely selling down all his shares now he doesn't have to inform the market via an Appendix 3Y (Change of Director's Interest Notice). Very shady if this is the case.

Does anyone not think that a market cap of $150M might be getting a little bit ahead of itself for a company that makes $0.7M in annual recurring subscription revenue a quarter? That's $2.8M a year annualised subscription revenue. Plus $3.2M in annualised rebate revenue. $6M likely group revenue for FY19. That's a 25x forwardRevenue multiple at today's SP. (Repeat: REVENUE multiple, not EBIT multiple). No profitability in sight, and unlikely to be if it continues with its aggressive international sales expansion. Trying to do too many markets at once. No focus. CR definitely coming.

I'd exercise serious caution here. I suspect the SP has been propped up by Baillieu family money, and strong promotion and marketing to other family offices until now. But they may have run out of puff. Smart money will come in on a heavily discounted placement.

Well done to all those who were smart enough to get out at $1.50+.

Expand

The finances is one of the reasons I have steered clear of investment in this company. 150m mcap is crazy!

BID Price at posting: $1.34 Sentiment: Sell Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

HotCopper Highlights: Your most watched stocks for Week 46, 2024

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

ME1

Banshee's historic trenches prove rich in antimony and gold for GDM

LYN

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

AN1

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

AUN

Cyclone signs MOU with Vale for development of Iron Bear play

EDE

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

There are more pages in this discussion • 12 more messages in this thread...

First 47 Last

Add BID (ASX) to my watchlist

The finances is one of the reasons I have steered clear of...

Top Stories

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

HotCopper Highlights: Your most watched stocks for Week 46, 2024

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Banshee's historic trenches prove rich in antimony and gold for GDM

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Cyclone signs MOU with Vale for development of Iron Bear play

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play